Tests aerobic exercise training in people with Parkinson's disease
Tests a 12-week supervised aerobic exercise program against usual care in adults with Parkinson's.
Key facts
- Who runs it
- Raphael Mendes Ritti Dias
- Where
- São Paulo, BrazilSee the site
- Trial code
- Registry title
- Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 28 Feb 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Aerobic training
- Usual Care
- Record updated
- 13 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Parkinson's disease at stages 1-3 who take stable medication and can walk on their own. It tests a 12-week supervised aerobic training program against usual care.
- Age
- 40 years and older
- Sex
- Men and women can join.
- Disease stage
- Clinical diagnosis of Parkinson's disease, Hoehn & Yahr stages 1-3.
- Earlier treatment
- Stable antiparkinsonian medication for at least 4 weeks.
- Biomarker or test result
- Montreal Cognitive Assessment (MoCA) score of 18 or higher.
Main reasons for not taking part
- A change in medication
- A contraindication to exercise
- Cannot walk independently (with or without an assistive device)
- No medical clearance for moderate-intensity exercise
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Clinical diagnosis of Parkinson's disease
- Hoehn \& Yahr stages 1-3
- Stable antiparkinsonian medication for at least 4 weeks
- Montreal Cognitive Assessment (MoCA) score ≥ 18
- Ability to walk independently (with or without assistive device)
- Medical clearance for participation in moderate-intensity exercise
Who cannot take part
- Change in medication
- Contraindication to exercise
Where in Brazil
- Associação Brasil ParkinsonSão Paulo, BrazilContact: Verônica Souza, MDTaking people
About the trial
What the trial wants to find out
This randomized controlled trial will investigate the effects of a 12-week supervised aerobic training program on cerebrovascular function, peripheral vascular health, cardiovascular autonomic modulation, cognition, non-motor symptoms, sleep, mood, gait biomechanics, quality of life, and body composition in patients with Parkinson's disease (Hoehn \& Yahr stages 1-3). Participants will be randomly allocated to aerobic training or usual care.
The 2 groups in the trial
- Aerobic TrainingTreatment being tested
Participants will perform supervised aerobic training on a cycle ergometer, 3 times per week for 12 weeks, 40 minutes per session, at perceived exertion 12-13 on Borg scale.
- Usual CareOther group
Participants will maintain their usual clinical care and daily activities without structured exercise intervention.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of Aerobic Training on Cerebrovascular Function, Cognitive Performance and Gait Parameters in Patients With Parkinson's Disease: A Randomized Controlled Trial
- Plain-language title
- Tests aerobic exercise training in people with Parkinson's diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 13 April 2026